US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US5650489A
(en)
*
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US6197529B1
(en)
*
|
1990-11-21 |
2001-03-06 |
Torrey Pines Institute For Molecular Studies |
Linear substituted oligoalkyleneimine libraries
|
US20050209121A1
(en)
*
|
1990-12-05 |
2005-09-22 |
Novozymes A/S |
Proteins with changed epitopes and methods for the production thereof
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
WO1993004204A1
(en)
*
|
1991-08-23 |
1993-03-04 |
Isis Pharmaceuticals, Inc. |
Synthetic unrandomization of oligomer fragments
|
WO1993005182A1
(en)
*
|
1991-09-05 |
1993-03-18 |
Isis Pharmaceuticals, Inc. |
Determination of oligonucleotides for therapeutics, diagnostics and research reagents
|
WO1993006121A1
(en)
|
1991-09-18 |
1993-04-01 |
Affymax Technologies N.V. |
Method of synthesizing diverse collections of oligomers
|
US5639603A
(en)
*
|
1991-09-18 |
1997-06-17 |
Affymax Technologies N.V. |
Synthesizing and screening molecular diversity
|
US6117974A
(en)
*
|
1991-10-02 |
2000-09-12 |
Peptor Limited |
Libraries of backbone-cyclized peptidomimetics
|
US20010021513A1
(en)
*
|
1991-11-21 |
2001-09-13 |
Puijk Wouter Cornelis |
Test device comprising a plate containing a multiplicity of wells with an associated metering device, as well as a kit which comprises these devices and use of the devices
|
US5573905A
(en)
*
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
WO1993021203A1
(en)
*
|
1992-04-15 |
1993-10-28 |
The Johns Hopkins University |
Synthesis of diverse and useful collections of oligonucleotides
|
US5541061A
(en)
*
|
1992-04-29 |
1996-07-30 |
Affymax Technologies N.V. |
Methods for screening factorial chemical libraries
|
WO1994002515A1
(en)
*
|
1992-07-21 |
1994-02-03 |
Bunsen Rush Laboratories Inc. |
Oligomer library formats and methods relating thereto
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
CA2143848C
(en)
*
|
1992-10-01 |
2007-09-11 |
W. Clark Still |
Complex combinatorial chemical libraries encoded with tags
|
US5807683A
(en)
*
|
1992-11-19 |
1998-09-15 |
Combichem, Inc. |
Combinatorial libraries and methods for their use
|
DE4243770A1
(de)
*
|
1992-12-23 |
1994-06-30 |
Behringwerke Ag |
Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung
|
US5605798A
(en)
*
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
AU6281594A
(en)
*
|
1993-03-12 |
1994-09-26 |
Jerini Bio Chemicals Gmbh |
Process for synthesizing and selecting sequences of covalently bound components
|
US6864048B2
(en)
|
1993-04-28 |
2005-03-08 |
Affymetrix, Inc. |
Factorial chemical libraries
|
US5840485A
(en)
*
|
1993-05-27 |
1998-11-24 |
Selectide Corporation |
Topologically segregated, encoded solid phase libraries
|
DK1310510T3
(da)
*
|
1993-05-27 |
2007-09-24 |
Aventis Pharma Inc |
Topologisk adsilte, kodede biblioteker med fast fase
|
EP0700522A1
(en)
*
|
1993-05-28 |
1996-03-13 |
Chiron Corporation |
Method for selection of biologically active peptide sequences
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
US5846731A
(en)
*
|
1993-06-17 |
1998-12-08 |
Torry Pines Institute For Molecular Studies |
Peralkylated oligopeptide mixtures
|
DK1156059T3
(da)
*
|
1993-06-21 |
2007-11-12 |
Aventis Pharma Inc |
Selektivt spaltelige linkere baseret på en methioningruppe og en estergruppe
|
JPH09500625A
(ja)
|
1993-07-09 |
1997-01-21 |
スミスクライン・ビーチャム・コーポレイション |
環状セミランダムペプチドライブラリー
|
AU7193494A
(en)
*
|
1993-07-21 |
1995-02-20 |
Oxford Glycosystems Ltd |
Saccharides, their synthesis and use
|
US6001982A
(en)
|
1993-07-29 |
1999-12-14 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides
|
EP0713533B1
(en)
*
|
1993-08-13 |
2002-07-10 |
Albany Molecular Research, Inc. |
Biocatalytic methods for synthesizing and identifying biologically active compounds
|
CN1525171A
(zh)
*
|
1993-10-01 |
2004-09-01 |
ŦԼ�и��ױ��Ǵ�ѧ���� |
用标示物编码的多元组合化学库
|
US5922545A
(en)
*
|
1993-10-29 |
1999-07-13 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US6165778A
(en)
*
|
1993-11-02 |
2000-12-26 |
Affymax Technologies N.V. |
Reaction vessel agitation apparatus
|
US5503805A
(en)
*
|
1993-11-02 |
1996-04-02 |
Affymax Technologies N.V. |
Apparatus and method for parallel coupling reactions
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
WO1995016209A1
(en)
*
|
1993-12-09 |
1995-06-15 |
Ciba-Geigy Ag |
Process for the production of combinatorial compound libraries
|
EP0734530B1
(en)
*
|
1993-12-15 |
1997-11-12 |
Combichem, Inc. |
Combinatorial libraries and methods for their use
|
US5587471A
(en)
*
|
1994-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
Method of making oligonucleotide libraries
|
WO1995019567A1
(en)
*
|
1994-01-13 |
1995-07-20 |
The Trustees Of Columbia University In The City Of New York |
Synthetic receptors, libraries and uses thereof
|
US5593853A
(en)
*
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5541085A
(en)
*
|
1994-02-14 |
1996-07-30 |
Zymogenetics, Inc. |
Method for preparing orphan receptor ligands
|
US5539083A
(en)
*
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
WO1995024186A1
(en)
*
|
1994-03-11 |
1995-09-14 |
Pharmacopeia, Inc. |
Sulfonamide derivatives and their use
|
US6015880A
(en)
*
|
1994-03-16 |
2000-01-18 |
California Institute Of Technology |
Method and substrate for performing multiple sequential reactions on a matrix
|
US6936477B2
(en)
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5856083A
(en)
*
|
1994-05-06 |
1999-01-05 |
Pharmacopeia, Inc. |
Lawn assay for compounds that affect enzyme activity or bind to target molecules
|
US5846841A
(en)
*
|
1994-05-20 |
1998-12-08 |
Selectide Corporation |
Motif Libraries
|
US6407059B1
(en)
|
1994-06-08 |
2002-06-18 |
Peptor Limited |
Conformationally constrained backbone cyclized peptide analogs
|
IL109943A
(en)
*
|
1994-06-08 |
2006-08-01 |
Develogen Israel Ltd |
Conformationally constrained backbone cyclized peptide analogs
|
EP0765477A4
(en)
*
|
1994-06-14 |
2004-11-17 |
Smithkline Beecham Corp |
RESIN FOR THE TEST PHASE SYNTHESIS
|
US5663046A
(en)
*
|
1994-06-22 |
1997-09-02 |
Pharmacopeia, Inc. |
Synthesis of combinatorial libraries
|
AU2871195A
(en)
*
|
1994-06-23 |
1996-01-19 |
Affymax Technologies N.V. |
Methods for the synthesis of diketopiperazines
|
US5817751A
(en)
*
|
1994-06-23 |
1998-10-06 |
Affymax Technologies N.V. |
Method for synthesis of diketopiperazine and diketomorpholine derivatives
|
JPH10506379A
(ja)
*
|
1994-07-26 |
1998-06-23 |
ザ・スクリプス・リサーチ・インスティチュート |
可溶性の組合せライブラリー
|
US5939268A
(en)
*
|
1994-07-26 |
1999-08-17 |
The Scripps Research Institute |
Combinatorial libraries of molecules and methods for producing same
|
US5948693A
(en)
*
|
1994-09-01 |
1999-09-07 |
Wisconsin Alumni Research Foundation |
Solid phase synthesis of immunosuppressive agents
|
US5463564A
(en)
*
|
1994-09-16 |
1995-10-31 |
3-Dimensional Pharmaceuticals, Inc. |
System and method of automatically generating chemical compounds with desired properties
|
US6558633B1
(en)
*
|
1994-09-21 |
2003-05-06 |
Isis Pharmaceuticals, Inc. |
Chemical reaction apparatus and methods
|
USRE43097E1
(en)
|
1994-10-13 |
2012-01-10 |
Illumina, Inc. |
Massively parallel signature sequencing by ligation of encoded adaptors
|
US6280935B1
(en)
|
1994-10-13 |
2001-08-28 |
Lynx Therapeutics, Inc. |
Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags
|
US5846719A
(en)
*
|
1994-10-13 |
1998-12-08 |
Lynx Therapeutics, Inc. |
Oligonucleotide tags for sorting and identification
|
US5604097A
(en)
*
|
1994-10-13 |
1997-02-18 |
Spectragen, Inc. |
Methods for sorting polynucleotides using oligonucleotide tags
|
US5695934A
(en)
*
|
1994-10-13 |
1997-12-09 |
Lynx Therapeutics, Inc. |
Massively parallel sequencing of sorted polynucleotides
|
AU3599895A
(en)
*
|
1994-10-14 |
1996-05-06 |
Chiron Mimotopes Pty Ltd |
Method and apparatus for efficient mimotope discovery
|
US6974666B1
(en)
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5556752A
(en)
*
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
US5688696A
(en)
*
|
1994-12-12 |
1997-11-18 |
Selectide Corporation |
Combinatorial libraries having a predetermined frequency of each species of test compound
|
DE4444260A1
(de)
*
|
1994-12-13 |
1996-06-20 |
Hoechst Ag |
Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung
|
AU5849796A
(en)
*
|
1994-12-27 |
1996-08-07 |
United Biomedical Inc. |
Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
|
GB9502225D0
(en)
*
|
1995-02-04 |
1995-03-22 |
Zeneca Ltd |
Method
|
US5759865A
(en)
*
|
1995-05-03 |
1998-06-02 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
WO1996035122A1
(en)
*
|
1995-05-03 |
1996-11-07 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
US5834318A
(en)
*
|
1995-05-10 |
1998-11-10 |
Bayer Corporation |
Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
AU5871196A
(en)
*
|
1995-05-23 |
1996-12-24 |
Hybridon, Inc. |
Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced
|
US5750674A
(en)
*
|
1995-05-23 |
1998-05-12 |
Hybridon, Inc. |
Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
US6051554A
(en)
*
|
1995-06-07 |
2000-04-18 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
US5770687A
(en)
*
|
1995-06-07 |
1998-06-23 |
Peptor Limited |
Comformationally constrained backbone cyclized somatostatin analogs
|
DE69619825T2
(de)
*
|
1995-06-21 |
2002-10-10 |
Martek Biosciences Corp., Columbia |
Kombinatorische bibliotheken aus markierten biochemischen verbindungen und verfahren zu ihrer herstellung
|
SE9502286D0
(sv)
*
|
1995-06-22 |
1995-06-22 |
Pharmacia Ab |
Process for detection, quantification and/or identification of a peptide
|
US6579848B1
(en)
*
|
1995-06-23 |
2003-06-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Depigmenting activity of agouti signal protein and peptides thereof
|
GB9515070D0
(en)
*
|
1995-07-22 |
1995-09-20 |
Zeneca Ltd |
Label
|
AU728668B2
(en)
*
|
1995-09-11 |
2001-01-18 |
La Jolla Cancer Research Foundation |
Molecules that home to a selected organ or tissue in vivo and methods of identifying same
|
US6068829A
(en)
*
|
1995-09-11 |
2000-05-30 |
The Burnham Institute |
Method of identifying molecules that home to a selected organ in vivo
|
US6743892B1
(en)
|
1995-09-11 |
2004-06-01 |
La Jolla Cancer Research Foundation |
Molecules that home to a selected organ in vivo
|
ES2299232T3
(es)
*
|
1995-09-11 |
2008-05-16 |
La Jolla Cancer Research Foundation |
Moleculas que migran hacia un organo o tejido seleccionado in vivo.
|
US7026114B1
(en)
*
|
1995-09-13 |
2006-04-11 |
Affymetrix, Inc. |
Methods and compositions for monitoring polymer array synthesis
|
US6841533B1
(en)
|
1995-12-07 |
2005-01-11 |
Peptor Limited |
Conformationally constrained backbone cyclized interleukin-6 antagonists
|
US20110028350A1
(en)
*
|
1995-12-15 |
2011-02-03 |
Affymetrix, Inc. |
Photocleavable protecting groups
|
US6147205A
(en)
*
|
1995-12-15 |
2000-11-14 |
Affymetrix, Inc. |
Photocleavable protecting groups and methods for their use
|
JP2000502897A
(ja)
*
|
1995-12-18 |
2000-03-14 |
プレーシス ファーマスーティカルズ インコーポレイテッド |
標的に結合する化合物を同定する方法
|
JP2001521484A
(ja)
*
|
1996-01-22 |
2001-11-06 |
イーライ・リリー・アンド・カンパニー |
置換されたインダンのライブラリーを製造するための組み合わせ方法
|
US6365344B1
(en)
*
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
WO1997027213A1
(en)
|
1996-01-23 |
1997-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and rna molecules
|
US6277583B1
(en)
*
|
1996-02-07 |
2001-08-21 |
Conjuchem, Inc. |
Affinity labeling libraries and applications thereof
|
US6080719A
(en)
*
|
1996-02-23 |
2000-06-27 |
Hoechst Aktiengesellschaft |
Cyclohexapeptides and their mixtures, a process for preparing them, and their use
|
WO1997033000A1
(en)
|
1996-03-04 |
1997-09-12 |
Genetrace Systems, Inc. |
Methods of screening nucleic acids using mass spectrometry
|
DE19610103A1
(de)
|
1996-03-15 |
1997-09-18 |
Basf Ag |
Cycloalkylderivate und ihre Synthese an fester Phase
|
CA2251781A1
(en)
*
|
1996-03-20 |
1997-09-25 |
Charles Nicolette |
A method for identifying cytotoxic t-cell epitopes
|
EP0901629A4
(en)
*
|
1996-03-21 |
2000-02-02 |
Univ Princeton |
CARBOHYDRATE LIBRARY, ASSAY AND METHOD
|
US5866341A
(en)
*
|
1996-04-03 |
1999-02-02 |
Chugai Pharmaceutical Co., Ltd. |
Compositions and methods for screening drug libraries
|
ATE366418T1
(de)
|
1996-04-25 |
2007-07-15 |
Bioarray Solutions Ltd |
Licht-regulierte, elektrokinetische zusammensetzung von partikeln an oberflächen
|
US6387707B1
(en)
|
1996-04-25 |
2002-05-14 |
Bioarray Solutions |
Array Cytometry
|
US7144119B2
(en)
|
1996-04-25 |
2006-12-05 |
Bioarray Solutions Ltd. |
System and method for programmable illumination pattern generation
|
US5958342A
(en)
*
|
1996-05-17 |
1999-09-28 |
Incyte Pharmaceuticals, Inc. |
Jet droplet device
|
DE19621177A1
(de)
|
1996-05-24 |
1997-11-27 |
Basf Ag |
Kohlenhydratderivate und ihre Synthese an fester Phase
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6696251B1
(en)
*
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6203978B1
(en)
*
|
1996-05-31 |
2001-03-20 |
Du Vergier Ltd. |
Capture of single stranded nucleic acids
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
CN102286077A
(zh)
|
1996-06-14 |
2011-12-21 |
明治乳业株式会社 |
T细胞表位肽
|
WO1997049430A1
(en)
*
|
1996-06-26 |
1997-12-31 |
Antigen Express, Inc. |
Immunotherapy by modulation of antigen presentation
|
DE19626762A1
(de)
|
1996-07-03 |
1998-01-08 |
Basf Ag |
Enzymatisch spaltbare Linker für Festphasensynthesen
|
US6355613B1
(en)
|
1996-07-31 |
2002-03-12 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
US5922872A
(en)
*
|
1996-08-01 |
1999-07-13 |
Isis Pharmaceuticals, Inc. |
Meta-benzylic and alpha-amido compositions and methods for preparing same
|
US5817489A
(en)
|
1996-08-01 |
1998-10-06 |
Isis Pharmaceuticals, Inc. |
Di-nitrogen heterocycle compositions
|
US6576239B1
(en)
|
1996-09-10 |
2003-06-10 |
The Burnham Institute |
Angiogenic homing molecules and conjugates derived therefrom
|
AU4351897A
(en)
|
1996-09-16 |
1998-04-02 |
Conjuchem, Inc. |
Affinity labeling libraries with tagged leaving groups
|
US5965363A
(en)
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5798035A
(en)
|
1996-10-03 |
1998-08-25 |
Pharmacopeia, Inc. |
High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay
|
US20020022227A1
(en)
*
|
1996-10-17 |
2002-02-21 |
Short Jay M. |
Morphatides: novel shape and structure libraries
|
US6838238B1
(en)
*
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6042789A
(en)
*
|
1996-10-23 |
2000-03-28 |
Glaxo Group Limited |
System for parallel synthesis of organic compounds
|
US6149869A
(en)
*
|
1996-10-23 |
2000-11-21 |
Glaxo Wellcome Inc. |
Chemical synthesizers
|
US6025371A
(en)
*
|
1996-10-28 |
2000-02-15 |
Versicor, Inc. |
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
|
US6413724B1
(en)
|
1996-10-28 |
2002-07-02 |
Versicor, Inc. |
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
|
US6571227B1
(en)
|
1996-11-04 |
2003-05-27 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system and computer program product for non-linear mapping of multi-dimensional data
|
CA2269669A1
(en)
|
1996-11-04 |
1998-05-14 |
3-Dimensional Pharmaceuticals, Inc. |
System, method and computer program product for identifying chemical compounds having desired properties
|
US6453246B1
(en)
|
1996-11-04 |
2002-09-17 |
3-Dimensional Pharmaceuticals, Inc. |
System, method, and computer program product for representing proximity data in a multi-dimensional space
|
US6083761A
(en)
*
|
1996-12-02 |
2000-07-04 |
Glaxo Wellcome Inc. |
Method and apparatus for transferring and combining reagents
|
US6054325A
(en)
*
|
1996-12-02 |
2000-04-25 |
Glaxo Wellcom Inc. |
Method and apparatus for transferring and combining distinct chemical compositions with reagents
|
WO1998024760A1
(en)
*
|
1996-12-03 |
1998-06-11 |
Graybill Todd L |
Aminobenzenedicarboxylic acid-based combinatorial libraries
|
CA2274587A1
(en)
|
1996-12-10 |
1998-06-18 |
Genetrace Systems Inc. |
Releasable nonvolatile mass-label molecules
|
EP0975792B1
(en)
*
|
1997-03-04 |
2007-10-10 |
Savient Pharmaceuticals, Inc. |
Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
|
US6045755A
(en)
*
|
1997-03-10 |
2000-04-04 |
Trega Biosciences,, Inc. |
Apparatus and method for combinatorial chemistry synthesis
|
US20030027126A1
(en)
|
1997-03-14 |
2003-02-06 |
Walt David R. |
Methods for detecting target analytes and enzymatic reactions
|
US7622294B2
(en)
*
|
1997-03-14 |
2009-11-24 |
Trustees Of Tufts College |
Methods for detecting target analytes and enzymatic reactions
|
US6177464B1
(en)
|
1997-03-14 |
2001-01-23 |
Sepracor, Inc. |
Ring opening metathesis of alkenes
|
JPH10260223A
(ja)
*
|
1997-03-19 |
1998-09-29 |
Fujitsu Ltd |
半導体検査装置及びこれを用いた検査方法
|
WO1998046631A1
(en)
*
|
1997-04-11 |
1998-10-22 |
Eli Lilly And Company |
Combinatorial libraries of peptidomimetic macrocycles and processes therefor
|
US5908960A
(en)
*
|
1997-05-07 |
1999-06-01 |
Smithkline Beecham Corporation |
Compounds
|
US6004823A
(en)
*
|
1997-05-07 |
1999-12-21 |
Smithkline Beecham Corporation |
Compounds
|
GB9710582D0
(en)
|
1997-05-22 |
1997-07-16 |
Oxford Glycosciences Uk Ltd |
A method for de novo peptide sequence determination
|
EP1003904B1
(en)
|
1997-05-23 |
2007-07-11 |
BioArray Solutions Ltd. |
Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
|
WO1998058256A1
(en)
*
|
1997-06-16 |
1998-12-23 |
The University Of North Carolina At Chapel Hill |
PEPTIDO OLIGONUCLEOTIDES (PONs) AND THEIR COMBINATORIAL LIBRARIES
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
EP1387390B1
(en)
|
1997-06-20 |
2009-02-18 |
Bio - Rad Laboratories, Inc. |
Retentate chromatography and protein chip arrays with applications in biology and medicine
|
US5874589A
(en)
*
|
1997-07-18 |
1999-02-23 |
Glaxo Wellcome, Inc. |
Methods for synthesizing diverse collections of tetramic acids and derivatives thereof
|
US6410342B1
(en)
*
|
1997-08-19 |
2002-06-25 |
Pharmacopeia, Inc. |
Method and apparatus for controlled photoelution
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
ATE406577T1
(de)
|
1997-11-07 |
2008-09-15 |
Conjuchem Biotechnologies Inc |
Methoden zum screening von affinitätsmarker- bibliotheken
|
US6228579B1
(en)
*
|
1997-11-14 |
2001-05-08 |
San Diego State University Foundation |
Method for identifying microbial proliferation genes
|
US6083682A
(en)
|
1997-12-19 |
2000-07-04 |
Glaxo Group Limited |
System and method for solid-phase parallel synthesis of a combinatorial collection of compounds
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US5968361A
(en)
*
|
1998-02-24 |
1999-10-19 |
Arqule, Inc. |
Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
|
US6497820B1
(en)
|
1998-02-03 |
2002-12-24 |
Arqule, Inc. |
Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
|
WO1999043409A1
(en)
*
|
1998-02-27 |
1999-09-02 |
Isis Pharmaceuticals, Inc. |
Hplc fractionation of complex chemical mixtures
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
EP1062508A1
(en)
|
1998-03-20 |
2000-12-27 |
The Rockefeller University |
Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
CA2324060A1
(en)
*
|
1998-03-30 |
1999-10-07 |
The Regents Of The University Of California |
Methods and compounds for modulating nuclear receptor activity
|
US6316616B1
(en)
|
1998-04-02 |
2001-11-13 |
President And Fellows Of Harvard College |
Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof
|
WO1999053295A1
(en)
|
1998-04-14 |
1999-10-21 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
DE19819889A1
(de)
*
|
1998-05-04 |
1999-11-11 |
Fraunhofer Ges Forschung |
Verfahren zur Isolierung von Nucleinsäuren
|
AU3931699A
(en)
|
1998-05-04 |
1999-11-23 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Method and device for isolating nucleic acids
|
EP1138692A1
(en)
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
US6872535B2
(en)
|
1998-05-20 |
2005-03-29 |
Aventis Pharmaceuticals Inc. |
Three-dimensional array of supports for solid-phase parallel synthesis and method of use
|
US6541211B1
(en)
*
|
1998-05-20 |
2003-04-01 |
Selectide Corporation |
Apparatus and method for synthesizing combinational libraries
|
US7387779B2
(en)
*
|
1998-06-17 |
2008-06-17 |
Beth Israel Deaconess Medical Center |
Anti-angiogenic proteins and fragments and methods of use thereof
|
US7402400B2
(en)
|
2001-07-03 |
2008-07-22 |
Regents Of The University Of California |
Mammalian sweet taste receptors
|
CA2337490C
(en)
*
|
1998-08-17 |
2012-01-03 |
Phylos, Inc. |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
US6633543B1
(en)
*
|
1998-08-27 |
2003-10-14 |
Intel Corporation |
Multicast flow control
|
US20040242521A1
(en)
*
|
1999-10-25 |
2004-12-02 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
US6867289B1
(en)
*
|
1998-10-26 |
2005-03-15 |
Board Of Regents, The University Of Texas Systems |
Thio-modified aptamer synthetic methods and compositions
|
AU1818400A
(en)
*
|
1998-11-12 |
2000-05-29 |
Eli Lilly And Company |
Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
|
US20030027214A1
(en)
*
|
1999-02-17 |
2003-02-06 |
Kamb Carl Alexander |
Methods for substrate-ligand interaction screening
|
US6649358B1
(en)
|
1999-06-01 |
2003-11-18 |
Caliper Technologies Corp. |
Microscale assays and microfluidic devices for transporter, gradient induced, and binding activities
|
CA2376232A1
(en)
|
1999-06-14 |
2000-12-21 |
Genentech, Inc. |
A structured peptide scaffold for displaying turn libraries on phage
|
SE9902479D0
(sv)
*
|
1999-06-30 |
1999-06-30 |
Amersham Pharm Biotech Ab |
Particle classification as marker
|
US7742877B1
(en)
|
1999-07-22 |
2010-06-22 |
Becton, Dickinson & Company |
Methods, apparatus and computer program products for formulating culture media
|
EP1218545B1
(en)
|
1999-08-18 |
2012-01-25 |
Illumina, Inc. |
Methods for preparing oligonucleotide solutions
|
CA2384115C
(en)
|
1999-09-03 |
2016-08-02 |
Brigham And Women's Hospital, Inc. |
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
|
US6420591B1
(en)
*
|
1999-10-04 |
2002-07-16 |
University Of Medicine And Dentistry Of New Jersey |
Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
|
US6569685B1
(en)
*
|
1999-10-05 |
2003-05-27 |
The Molecular Sciences Institute, Inc. |
Protein fingerprint system and related methods
|
KR100378252B1
(ko)
*
|
1999-11-12 |
2003-03-29 |
학교법인 포항공과대학교 |
니트로술포닐에톡시카르보닐-아미노산을 이용한 합성테트라펩티드 라이브러리의 제조방법
|
US6458538B1
(en)
|
1999-12-14 |
2002-10-01 |
Ptc Therapeutics, Inc. |
Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
|
US7452664B2
(en)
|
1999-12-15 |
2008-11-18 |
Massachusetts Institute Of Technology |
Methods for identifying agents which alter histone protein acetylation
|
US8642284B1
(en)
|
1999-12-15 |
2014-02-04 |
Massachusetts Institute Of Technology |
Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
|
US6489116B2
(en)
|
2000-01-24 |
2002-12-03 |
Phylos, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
US7022479B2
(en)
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
EP1251904A1
(en)
|
2000-02-03 |
2002-10-30 |
The Regents of the University of California |
Assays for the detection of agents that affect cognition
|
US7416524B1
(en)
|
2000-02-18 |
2008-08-26 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
System, method and computer program product for fast and efficient searching of large chemical libraries
|
WO2001065462A2
(en)
|
2000-02-29 |
2001-09-07 |
3-Dimensional Pharmaceuticals, Inc. |
Method and computer program product for designing combinatorial arrays
|
TW201006846A
(en)
|
2000-03-07 |
2010-02-16 |
Senomyx Inc |
T1R taste receptor and genes encidung same
|
US7039621B2
(en)
|
2000-03-22 |
2006-05-02 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
System, method, and computer program product for representing object relationships in a multidimensional space
|
US20050037430A1
(en)
*
|
2000-03-29 |
2005-02-17 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
USRE43279E1
(en)
|
2000-03-29 |
2012-03-27 |
Biotemp B.V. |
Compositions capable of reducing elevated blood urea concentration
|
WO2001075790A2
(en)
|
2000-04-03 |
2001-10-11 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system, and computer program product for representing object relationships in a multidimensional space
|
US6660229B2
(en)
|
2000-06-13 |
2003-12-09 |
The Trustees Of Boston University |
Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
|
US9709559B2
(en)
|
2000-06-21 |
2017-07-18 |
Bioarray Solutions, Ltd. |
Multianalyte molecular analysis using application-specific random particle arrays
|
AU7299301A
(en)
|
2000-06-21 |
2002-01-02 |
Bioarray Solutions Ltd |
Multianalyte molecular analysis using application-specific random particle arrays
|
US6759510B1
(en)
*
|
2000-06-30 |
2004-07-06 |
Becton, Dickinson And Company |
Peptides for use in culture media
|
US20020019010A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Stockwell Brent R. |
Methods for identifying combinations of entities as therapeutics
|
US20040253627A1
(en)
*
|
2000-07-07 |
2004-12-16 |
Grant Zimmermann |
System and method for multidimensional evaluation of combinations of compositions
|
US20020051991A1
(en)
*
|
2000-07-11 |
2002-05-02 |
Zhi Hong |
Rapid generation of diverse nucleoside and nucleotide libraries
|
WO2002014867A2
(en)
*
|
2000-08-11 |
2002-02-21 |
Agilix Corporation |
Ultra-sensitive detection systems
|
US6963807B2
(en)
|
2000-09-08 |
2005-11-08 |
Oxford Glycosciences (Uk) Ltd. |
Automated identification of peptides
|
US7420030B2
(en)
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
US7452964B2
(en)
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
US20040170955A1
(en)
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
WO2002020150A2
(en)
*
|
2000-09-11 |
2002-03-14 |
Affymetrix, Inc. |
Photocleavable protecting groups
|
US20020094530A1
(en)
*
|
2000-09-18 |
2002-07-18 |
Nicolette Charles A. |
Method to identify antibody targets
|
WO2002026107A2
(en)
|
2000-09-25 |
2002-04-04 |
The Regents Of The University Of California |
Model for neurodegenerative diseases involving amyloid accumulation
|
US20030045005A1
(en)
*
|
2000-10-17 |
2003-03-06 |
Michael Seul |
Light-controlled electrokinetic assembly of particles near surfaces
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
US7572575B2
(en)
|
2000-12-13 |
2009-08-11 |
Massachusetts Institute Of Technology |
SIR2 activity
|
WO2002052046A2
(en)
*
|
2000-12-23 |
2002-07-04 |
Chiron Corporation |
Oligonucleotide transfection screening method
|
TW201022287A
(en)
|
2001-01-03 |
2010-06-16 |
Senomyx Inc |
T1R taste receptors and genes encoding same
|
US7054757B2
(en)
|
2001-01-29 |
2006-05-30 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Method, system, and computer program product for analyzing combinatorial libraries
|
DE10106339A1
(de)
*
|
2001-02-09 |
2002-08-22 |
Hans-Joachim Mueller |
Verfahren zum Hochdurchsatz-Screening von Kandidaten-Verbindungen über die Hochdurchsatz-Direktsynthese von rekombinanten Polypeptiden
|
US7883856B2
(en)
|
2001-04-05 |
2011-02-08 |
Senomyx Inc. |
Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
US20060228730A1
(en)
*
|
2001-04-11 |
2006-10-12 |
Rando Robert F |
Methods for identifying small molecules that bind specific RNA structural motifs
|
WO2002083837A1
(en)
*
|
2001-04-11 |
2002-10-24 |
Ptc Therapeutics, Inc. |
Methods for identifying small molecules that bind specific rna structural motifs
|
US6649573B2
(en)
*
|
2001-04-13 |
2003-11-18 |
Michael J. Mitrovich |
Solid lubricant and composition
|
US6914123B2
(en)
|
2001-04-17 |
2005-07-05 |
Genentech, Inc. |
Hairpin peptides with a novel structural motif and methods relating thereto
|
US7803982B2
(en)
|
2001-04-20 |
2010-09-28 |
The Mount Sinai School Of Medicine Of New York University |
T1R3 transgenic animals, cells and related methods
|
AU2002310012A1
(en)
|
2001-05-21 |
2002-12-03 |
Monogram Biosciences, Inc. |
Methods and compositions for analyzing proteins
|
US20030148380A1
(en)
*
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20050164515A9
(en)
*
|
2001-06-05 |
2005-07-28 |
Belcher Angela M. |
Biological control of nanoparticle nucleation, shape and crystal phase
|
JP4342934B2
(ja)
|
2001-06-11 |
2009-10-14 |
キセノポート インコーポレーティッド |
Pept−2輸送体を介した薬剤の投与
|
US7727713B2
(en)
|
2001-06-20 |
2010-06-01 |
Nuevolution A/S |
Templated molecules and methods for using such molecules
|
US7262063B2
(en)
|
2001-06-21 |
2007-08-28 |
Bio Array Solutions, Ltd. |
Directed assembly of functional heterostructures
|
AU2002326315B2
(en)
|
2001-06-26 |
2007-07-05 |
Senomyx, Inc. |
T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
|
EP1414491A4
(en)
|
2001-07-09 |
2005-07-06 |
Elan Pharm Inc |
METHOD OF INHIBITING THE TOXICITY OF AMYLOID
|
US6800449B1
(en)
*
|
2001-07-13 |
2004-10-05 |
Syngenta Participations Ag |
High throughput functional proteomics
|
US7413870B2
(en)
|
2001-08-01 |
2008-08-19 |
Rigel Pharmaceuticals, Incorporated |
SAK: modulation of cellular proliferation for treatment of cancer
|
US6767731B2
(en)
*
|
2001-08-27 |
2004-07-27 |
Intel Corporation |
Electron induced fluorescent method for nucleic acid sequencing
|
TW573125B
(en)
*
|
2001-08-29 |
2004-01-21 |
Combinatorx Inc |
A screening system for identifying drug-drug interactions and methods of use thereof
|
US20030073104A1
(en)
*
|
2001-10-02 |
2003-04-17 |
Belcher Angela M. |
Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
|
ES2712173T3
(es)
|
2001-10-15 |
2019-05-09 |
Bioarray Solutions Ltd |
Análisis multiplexado de loci polimórficos mediante consulta simultánea y detección mediada por enzimas
|
WO2003035679A2
(en)
|
2001-10-25 |
2003-05-01 |
Medical Research Council |
Molecules
|
US6670142B2
(en)
|
2001-10-26 |
2003-12-30 |
The Regents Of The University Of California |
Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells
|
US7262269B2
(en)
|
2001-10-26 |
2007-08-28 |
The Regents Of University Of California |
Method for screening combinational bead library; ligands for cancer cells
|
US20030124595A1
(en)
*
|
2001-11-06 |
2003-07-03 |
Lizardi Paul M. |
Sensitive coded detection systems
|
EP1527341B1
(en)
*
|
2001-11-20 |
2009-06-17 |
Duke University |
Interfacial biomaterials
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
WO2003052053A2
(en)
*
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Nucleoside libraries and compounds by mcc combinatorial strategies on solid support
|
US7291456B2
(en)
|
2002-01-24 |
2007-11-06 |
The Regents Of The University Of California |
Method for determining differences in molecular interactions and for screening a combinatorial library
|
EP1470551A2
(en)
*
|
2002-01-28 |
2004-10-27 |
Burstein Technologies, Inc. |
Methods and apparatus for logical triggering
|
CA2471017A1
(en)
|
2002-01-31 |
2003-08-07 |
Burstein Technologies, Inc. |
Method for triggering through disc grooves and related optical analysis discs and system
|
AU2003209054A1
(en)
*
|
2002-02-07 |
2003-09-02 |
Discovery Genomics, Inc. |
Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof
|
EP1572906A4
(en)
|
2002-03-04 |
2008-05-28 |
Bristol Myers Squibb Co |
NEW PAVIAN TAFI-CODING NUCLEIC ACID MOLECULES AND POLYPEPTIDES
|
NZ535144A
(en)
|
2002-03-15 |
2006-03-31 |
Nuevolution As |
An improved method for synthesising templated molecules
|
US7544767B2
(en)
|
2002-04-05 |
2009-06-09 |
Burnham Institute For Medical Research |
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
|
US7223734B2
(en)
|
2002-04-15 |
2007-05-29 |
The American National Red Cross |
Plasma protein-binding ligands
|
US20060275753A1
(en)
*
|
2002-04-15 |
2006-12-07 |
Hammond David J |
Recovery of analytes using combinatorial libraries
|
CA2486486A1
(en)
*
|
2002-05-17 |
2004-05-06 |
Alfred E. Slanetz |
Process for determining target function and identifying drug leads
|
US7893218B2
(en)
|
2003-06-16 |
2011-02-22 |
Stowers Institute For Medical Research |
Antibodies that specifically bind SOST peptides
|
AU2003247610A1
(en)
*
|
2002-06-21 |
2004-01-06 |
Ptc Therapeutics, Inc. |
METHODS FOR IDENTIFYING SMALL MOLECULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
|
US20100168037A1
(en)
*
|
2002-07-03 |
2010-07-01 |
Bio Science International, Inc. |
Peptides comprising aromatic d-amino acids and methods of use
|
CA2491969A1
(en)
|
2002-07-11 |
2004-01-22 |
The American National Red Cross |
Method for identifying individual active entities from complex mixtures
|
US7301006B2
(en)
*
|
2002-07-16 |
2007-11-27 |
Wisconsin Alumni Research Foundation |
Methods and materials for the synthesis of modified peptides
|
WO2004010106A2
(en)
*
|
2002-07-24 |
2004-01-29 |
Ptc Therapeutics, Inc. |
METHODS FOR IDENTIFYING SMALL MOLEDULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
|
AU2003247266A1
(en)
|
2002-08-01 |
2004-02-23 |
Nuevolution A/S |
Multi-step synthesis of templated molecules
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
PT2277551E
(pt)
|
2002-09-06 |
2013-08-22 |
Cerulean Pharma Inc |
Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
|
US7157228B2
(en)
*
|
2002-09-09 |
2007-01-02 |
Bioarray Solutions Ltd. |
Genetic analysis and authentication
|
US20050064508A1
(en)
*
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
CA2502610A1
(en)
*
|
2002-10-16 |
2005-01-13 |
Board Of Regents Of The University Of Texas System |
Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
|
AU2003272169A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Biacore Ab |
Assay with co-immobilized ligands
|
HUE033651T2
(en)
|
2002-10-30 |
2017-12-28 |
Nuevolution As |
A method for producing two-function complexes
|
WO2004047007A1
(en)
|
2002-11-15 |
2004-06-03 |
Bioarray Solutions, Ltd. |
Analysis, secure access to, and transmission of array images
|
CA2836951C
(en)
|
2002-12-03 |
2017-01-10 |
North Carolina State University |
Prion protein ligands and methods of use
|
US20040185473A1
(en)
*
|
2002-12-17 |
2004-09-23 |
Affymetrix, Inc. |
Releasable polymer arrays
|
EP2175019A3
(en)
|
2002-12-19 |
2011-04-06 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
US7736909B2
(en)
*
|
2003-01-09 |
2010-06-15 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising capture agents
|
AT413945B
(de)
*
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
WO2004074429A2
(en)
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
Method for producing second-generation library
|
GB0305448D0
(en)
*
|
2003-03-10 |
2003-04-16 |
Tcp Innovations Ltd |
Immunoassay
|
US20040185499A1
(en)
*
|
2003-03-20 |
2004-09-23 |
Jolley Michael E. |
Method of epitope scanning using fluorescence polarization
|
US20040235054A1
(en)
*
|
2003-03-28 |
2004-11-25 |
The Regents Of The University Of California |
Novel encoding method for "one-bead one-compound" combinatorial libraries
|
US20040235053A1
(en)
*
|
2003-03-28 |
2004-11-25 |
The Regents Of The University Of California |
Preparation and application of encoded bead aggregates in combinatorial chemistry
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
WO2004087865A2
(en)
*
|
2003-03-31 |
2004-10-14 |
The Regents Of The University Of California |
The preparation and application of ligand-biopolymer conjugates
|
GB0307428D0
(en)
*
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
US7510848B2
(en)
|
2003-04-04 |
2009-03-31 |
North Carolina State University |
Prion protein binding materials and methods of use
|
NZ543371A
(en)
|
2003-04-04 |
2008-04-30 |
Pathogen Removal And Diagnosti |
Prion protein binding materials and methods of use
|
US20040210036A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Nanogen, Inc. |
Peptide substrate libraries
|
US7858044B2
(en)
|
2003-04-30 |
2010-12-28 |
Nexus Biosystems, Inc. |
Multi-well plate providing a high-density storage and assay platform
|
WO2005032455A2
(en)
*
|
2003-05-23 |
2005-04-14 |
Board Of Regents |
Combinatorially selected phosphorodithioate aptamer targeting ap-1
|
CA2526691A1
(en)
*
|
2003-05-23 |
2005-04-28 |
Board Of Regents - The University Of Texas System |
High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens
|
CN101090729B
(zh)
|
2003-05-30 |
2014-07-23 |
艾更斯司股份有限公司 |
前列腺干细胞抗原(psca)变体及其序列
|
US7672791B2
(en)
*
|
2003-06-13 |
2010-03-02 |
International Business Machines Corporation |
Method of performing three-dimensional molecular superposition and similarity searches in databases of flexible molecules
|
EP1648909A4
(en)
*
|
2003-07-24 |
2008-11-12 |
Univ Texas |
THIOAPTAMERS FOR DISCOVERING PHYSIOLOGICAL PATHWAYS AND NEW THERAPEUTIC STRATEGIES
|
MXPA06001510A
(es)
|
2003-08-06 |
2006-09-04 |
Senomyx Inc |
Receptores de degustacion hetero-oligomericos t1r, lineas celulares que expresan tales receptores y compuestos de degustacion.
|
WO2005029705A2
(en)
|
2003-09-18 |
2005-03-31 |
Bioarray Solutions, Ltd. |
Number coding for identification of subtypes of coded types of solid phase carriers
|
US11118215B2
(en)
|
2003-09-18 |
2021-09-14 |
Nuevolution A/S |
Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
|
ATE532066T1
(de)
|
2003-09-22 |
2011-11-15 |
Bioarray Solutions Ltd |
Oberflächenimmobilisierter polyelektrolyt mit mehreren, zur kovalenten bindung an biomoleküle fähigen funktionellen gruppen
|
WO2005035552A2
(en)
*
|
2003-10-07 |
2005-04-21 |
Genzyme Corporation |
Transducing combinatorial peptide library
|
AU2004286252A1
(en)
|
2003-10-28 |
2005-05-12 |
Bioarray Solutions Ltd. |
Optimization of gene expression analysis using immobilized capture probes
|
EP1694859B1
(en)
|
2003-10-29 |
2015-01-07 |
Bioarray Solutions Ltd |
Multiplexed nucleic acid analysis by fragmentation of double-stranded dna
|
EP2369347A1
(en)
|
2003-11-07 |
2011-09-28 |
Ciphergen Biosystems, Inc. |
Biomarkers for Alzheimer's disease
|
EP1701611B1
(en)
|
2003-12-24 |
2011-05-18 |
G2 Inflammation Pty Ltd |
Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar
|
US20050164167A1
(en)
*
|
2004-01-28 |
2005-07-28 |
Buscher Benjamin A. |
Method of discovery and development of broad-spectrum antiviral drugs
|
US20050221339A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
RS52918B
(en)
|
2004-04-02 |
2014-02-28 |
The Regents Of The University Of California |
PROCEDURES AND MIXTURES FOR TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH ALFA V BETA 5 INTEGRINE
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
KR101228356B1
(ko)
|
2004-04-08 |
2013-02-05 |
바이오매트리카 인코포레이티드 |
생명과학용 시료 보관 및 시료 관리의 통합
|
US20050239134A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
|
US7939251B2
(en)
|
2004-05-06 |
2011-05-10 |
Roche Molecular Systems, Inc. |
SENP1 as a marker for cancer
|
ES2330538T3
(es)
|
2004-05-25 |
2009-12-11 |
2Curex Aps |
Identificacion de compuestos que modifican una respuesta celular.
|
EP2583981A3
(en)
|
2004-05-28 |
2013-07-31 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
CA2571243A1
(en)
|
2004-06-21 |
2006-01-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
|
JP4507080B2
(ja)
*
|
2004-07-30 |
2010-07-21 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
US7848889B2
(en)
|
2004-08-02 |
2010-12-07 |
Bioarray Solutions, Ltd. |
Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
|
KR101400505B1
(ko)
|
2004-08-20 |
2014-05-28 |
버크 인스티튜트 포 에이지 리서치 |
P53 기능을 대체하거나 작동시키는 소형 분자
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
US7850960B2
(en)
|
2004-12-30 |
2010-12-14 |
University Of Washington |
Methods for regulation of stem cells
|
US7547775B2
(en)
|
2004-12-31 |
2009-06-16 |
Affymetrix, Inc. |
Parallel preparation of high fidelity probes in an array format
|
US8338093B2
(en)
*
|
2004-12-31 |
2012-12-25 |
Affymetrix, Inc. |
Primer array synthesis and validation
|
WO2006084130A2
(en)
*
|
2005-02-03 |
2006-08-10 |
Perkinelmer Las, Inc. |
Ultra-sensitive detection systems using multidimension signals
|
US20100196509A1
(en)
|
2005-02-28 |
2010-08-05 |
Jonathan Braun |
Methods for Diagnosis and Treatment of Endometrial Cancer
|
US20100240770A1
(en)
*
|
2005-03-11 |
2010-09-23 |
Jifa Qi |
Synthesis and use of colloidal III-V nanoparticles
|
WO2006100449A1
(en)
|
2005-03-19 |
2006-09-28 |
Medical Research Council |
Improvements in or relating to treatment and prevention of viral infections
|
US7989590B2
(en)
|
2005-03-22 |
2011-08-02 |
Rohto Pharmaceutical Co., Ltd |
Peptides that increase collagen or hyaluronic acid production
|
JP4841618B2
(ja)
|
2005-03-23 |
2011-12-21 |
バイオ−ラッド ラボラトリーズ インコーポレーティッド |
タンパク質を精製するための方法
|
RU2413735C2
(ru)
|
2005-03-31 |
2011-03-10 |
Эдженсис, Инк. |
Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
US20070099830A1
(en)
|
2005-04-21 |
2007-05-03 |
Massachusetts Institute Of Technology |
Sirt4 activities
|
WO2006124644A2
(en)
*
|
2005-05-12 |
2006-11-23 |
Board Of Regents, The University Of Texas System |
Protein and antibody profiling using small molecule microarrays
|
US8486629B2
(en)
|
2005-06-01 |
2013-07-16 |
Bioarray Solutions, Ltd. |
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
JP5189977B2
(ja)
|
2005-07-19 |
2013-04-24 |
ステムジェン ソシエタ ペル アチオニ |
Lifおよびbmpによる腫瘍性幹細胞の潜在的腫瘍形成能力の抑制
|
WO2007022530A2
(en)
*
|
2005-08-16 |
2007-02-22 |
The Children's Mercy Hospital |
Quantification of microsphere suspension hybridization and uses thereof
|
US7943134B2
(en)
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
US7781209B2
(en)
|
2005-09-25 |
2010-08-24 |
Multispan, Inc. |
GPCR-expressing cell lines
|
WO2007047988A2
(en)
|
2005-10-20 |
2007-04-26 |
Senomyx, Inc. |
Chimeric human sweet-umami and umami-sweet taste receptors
|
US8119572B2
(en)
|
2005-10-24 |
2012-02-21 |
Wisconsin Alumni Research Foundation |
Methods for determining protein binding specificity using peptide libraries
|
AU2006311827A1
(en)
|
2005-11-03 |
2007-05-18 |
Redpoint Bio Corporation |
High throughput screening assay for the TRPM5 ion channel
|
WO2007056352A2
(en)
|
2005-11-07 |
2007-05-18 |
The Scripps Research Institute |
Compositions and methods for controlling tissue factor signaling specificity
|
CA2629299C
(en)
|
2005-11-12 |
2017-08-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Fgf2-related methods for diagnosing and treating depression
|
US7576037B2
(en)
|
2005-11-18 |
2009-08-18 |
Mei Technologies, Inc. |
Process and apparatus for combinatorial synthesis
|
PT3305900T
(pt)
|
2005-12-01 |
2021-10-27 |
Nuevolution As |
Métodos de codificação enzimática para síntese eficaz de bibliotecas grandes
|
GB2433505A
(en)
*
|
2005-12-20 |
2007-06-27 |
Sharp Kk |
Capture agents for binding a ligand
|
GB2433591A
(en)
*
|
2005-12-20 |
2007-06-27 |
Sharp Kk |
Method for functionalising a hydrophobic substrate
|
GB2433506A
(en)
*
|
2005-12-20 |
2007-06-27 |
Sharp Kk |
A method of producing a multimeric capture agent
|
WO2007087113A2
(en)
|
2005-12-28 |
2007-08-02 |
The Scripps Research Institute |
Natural antisense and non-coding rna transcripts as drug targets
|
EP2364774A3
(en)
*
|
2006-01-11 |
2014-06-04 |
Raindance Technologies, Inc. |
Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors
|
US8859209B2
(en)
*
|
2006-01-12 |
2014-10-14 |
Carviar Aps |
Reimmunization and antibody design
|
WO2007092777A2
(en)
*
|
2006-02-02 |
2007-08-16 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
US20100278821A1
(en)
|
2006-03-21 |
2010-11-04 |
The Regents Of The University Of California |
N-cadherin: target for cancer diagnosis and therapy
|
WO2007109347A2
(en)
|
2006-03-21 |
2007-09-27 |
The Regents Of The University Of California |
N-cadherin and ly6 e: targets for cancer diagnosis and therapy
|
DK3235811T3
(en)
|
2006-04-21 |
2018-11-12 |
Senomyx Inc |
PROCEDURE FOR THE PREPARATION OF OXALAMIDS
|
CA2649295A1
(en)
*
|
2006-04-21 |
2007-11-01 |
Wyeth |
Methods for high-throughput screening of cell lines
|
PL2027158T3
(pl)
*
|
2006-05-02 |
2013-02-28 |
Carviar Aps |
Sposób immunizacji gatunków ptaków
|
US8551711B2
(en)
|
2006-05-02 |
2013-10-08 |
Teikyo University |
Screening method of glutathione-increasing substance
|
EP2021113A2
(en)
|
2006-05-11 |
2009-02-11 |
Raindance Technologies, Inc. |
Microfluidic devices
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
EP1865316B1
(en)
|
2006-06-07 |
2010-02-24 |
Nutrinova Nutrition Specialties & Food Ingredients GmbH |
Screening methods for compounds that modulate the activity of G-protein coupled receptors
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
US7674594B2
(en)
|
2006-07-27 |
2010-03-09 |
Redpoint Bio Corporation |
Screening assay for inhibitors of TRPA1 activation by a lower alkyl phenol
|
EP2077912B1
(en)
|
2006-08-07 |
2019-03-27 |
The President and Fellows of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
JP2010501172A
(ja)
|
2006-08-25 |
2010-01-21 |
オンコセラピー・サイエンス株式会社 |
肺癌に対する予後マーカーおよび治療標的
|
EP2589961A3
(en)
|
2006-09-06 |
2013-08-07 |
The Regents of the University of California |
Molecular diagnosis and classification of malignant melanoma
|
US20090252745A1
(en)
*
|
2006-09-15 |
2009-10-08 |
Duke University |
Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
|
US20110294782A1
(en)
|
2006-11-10 |
2011-12-01 |
Massachusetts Institute Of Technology |
Small molecule pak inhibitors
|
US9316633B2
(en)
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
EP2114396A4
(en)
|
2006-12-29 |
2010-03-10 |
Salk Inst For Biological Studi |
METHOD FOR IMPROVING TRAINING PERFORMANCE
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US20080269065A1
(en)
*
|
2007-04-30 |
2008-10-30 |
Syntrix Biosystems, Inc. |
Conformationally Constrained Analytical Probes
|
KR101440153B1
(ko)
*
|
2007-05-09 |
2014-09-15 |
재단법인서울대학교산학협력재단 |
펩타이드 라이브러리를 이용한 단백질 인산화 효소의기질특이성 분석 방법
|
EP2572712A3
(en)
|
2007-06-01 |
2013-11-20 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
US10092524B2
(en)
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
CA2690600C
(en)
*
|
2007-06-11 |
2016-10-11 |
R. Loch Macdonald |
A drug delivery system for the prevention of cerebral vasospasm
|
US8334239B2
(en)
*
|
2007-07-10 |
2012-12-18 |
The Board Of Regents Of The University Of Texas System |
High affinity VEGF-receptor antagonists
|
WO2009021077A2
(en)
*
|
2007-08-06 |
2009-02-12 |
THE GOVERMENT OF THE UNITED STATES OF AMERICA. as represented by THE SECRETARY OF THE NAVY |
Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same
|
EP2191014B1
(en)
|
2007-08-13 |
2013-04-03 |
Baxter International Inc. |
Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease
|
US8703161B2
(en)
*
|
2007-08-13 |
2014-04-22 |
Elc Management, Llc |
Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
|
EP2195656A4
(en)
|
2007-08-21 |
2011-10-19 |
Senomyx Inc |
HUMAN T2R BITTERITY RECEPTORS AND USES THEREOF
|
CA2702025A1
(en)
|
2007-10-01 |
2009-04-09 |
Redpoint Bio Corporation |
A non-desensitizing mutant of the transient receptor potential trpm5 ion channel
|
WO2009046407A2
(en)
|
2007-10-04 |
2009-04-09 |
Zymogenetics, Inc. |
B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
|
CA2703165A1
(en)
|
2007-10-22 |
2009-04-30 |
The Regents Of The University Of California |
Biomarkers for prenatal diagnosis of congenital cytomegalovirus
|
WO2010008411A1
(en)
|
2007-11-09 |
2010-01-21 |
The Salk Institute For Biological Studies |
Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
|
WO2009079373A2
(en)
|
2007-12-14 |
2009-06-25 |
The Regents Of The University Of California |
Inhibitors of calcium-activated chloride channels
|
EP2077272A1
(en)
*
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
US9187535B2
(en)
|
2007-12-19 |
2015-11-17 |
Affibody Ab |
Polypeptide derived from protein A and able to bind PDGF
|
EP2072525A1
(en)
|
2007-12-21 |
2009-06-24 |
Affibody AB |
New polypeptides having affinity for HER2
|
DK2518509T3
(da)
|
2008-03-05 |
2014-08-18 |
Univ California |
Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIP
|
CN104694570B
(zh)
|
2008-03-17 |
2019-07-16 |
斯克里普斯研究所 |
用于产生诱导的多能干细胞的组合化学遗传方法
|
WO2009131957A2
(en)
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising oxadiazole derivatives
|
CN102083850B
(zh)
|
2008-04-21 |
2015-08-12 |
加利福尼亚大学董事会 |
选择性高亲和力多齿配体及其制备方法
|
SG157299A1
(en)
|
2008-05-09 |
2009-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
AU2009266924B2
(en)
|
2008-07-01 |
2015-12-10 |
Genocea Biosciences, Inc. |
Antigen screening system
|
EP2315629B1
(en)
|
2008-07-18 |
2021-12-15 |
Bio-Rad Laboratories, Inc. |
Droplet libraries
|
US12038438B2
(en)
|
2008-07-18 |
2024-07-16 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
US20110262485A1
(en)
|
2008-08-04 |
2011-10-27 |
University Of Miami |
Sting (stimulator of interferon genes), a regulator of innate immune responses
|
US8338565B2
(en)
|
2008-08-20 |
2012-12-25 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for inhibition of tumor necrosis factor alpha
|
EP2352841A2
(en)
|
2008-09-23 |
2011-08-10 |
President and Fellows of Harvard College |
Sirt4 and uses thereof
|
CA2737795A1
(en)
|
2008-09-25 |
2010-04-01 |
University Of Guelph |
Nitrogen responsive early nodulin gene
|
KR101151805B1
(ko)
|
2008-10-20 |
2012-06-01 |
광주과학기술원 |
바이포달 펩타이드 바인더
|
CA2779958A1
(en)
|
2008-11-06 |
2010-05-14 |
University Of Miami |
Role of soluble upar in the pathogenesis of proteinuric kidney disease
|
WO2010054379A2
(en)
|
2008-11-10 |
2010-05-14 |
The United States Of America, As Represensted By The Secretary, Department Of Health And Human Services |
Gene signature for predicting prognosis of patients with solid tumors
|
EP2370450A1
(en)
|
2008-11-27 |
2011-10-05 |
Roche Diagnostics GmbH |
Directed synthesis of oligophosphoramidate stereoisomers
|
CA2745266C
(en)
|
2008-12-03 |
2018-04-10 |
Yue Xu |
Stem cell cultures
|
ES2629630T3
(es)
|
2008-12-04 |
2017-08-11 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con eritropoyetina (EPO) mediante inhibición del transcrito antisentido natural a EPO
|
WO2010065671A2
(en)
|
2008-12-04 |
2010-06-10 |
Curna, Inc. |
Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
|
KR101866152B1
(ko)
|
2008-12-04 |
2018-06-08 |
큐알엔에이, 인크. |
종양 억제 유전자에 대한 천연 안티센스 전사체의 억제에 의해 종양 억제 유전자 관련된 질환의 치료
|
WO2010077894A2
(en)
|
2008-12-16 |
2010-07-08 |
Bristol-Myers Squibb Company |
Methods of inhibiting quiescent tumor proliferation
|
EP3312269A1
(en)
|
2008-12-17 |
2018-04-25 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
US20120165650A1
(en)
|
2010-12-22 |
2012-06-28 |
General Electric Company |
Her2 binders
|
CN101768213B
(zh)
|
2008-12-30 |
2012-05-30 |
中国科学院遗传与发育生物学研究所 |
一种与植物分蘖数目相关的蛋白及其编码基因与应用
|
ES2762610T3
(es)
|
2009-02-12 |
2020-05-25 |
Curna Inc |
Tratamiento de enfermedades relacionadas con el factor neurotrófico derivado de cerebro (BDNF) por inhibición de transcrito antisentido natural para BDNF
|
CN101817879A
(zh)
|
2009-02-26 |
2010-09-01 |
中国科学院遗传与发育生物学研究所 |
金属硫蛋白及其编码基因与应用
|
EP2408919B1
(en)
|
2009-03-16 |
2017-10-18 |
CuRNA, Inc. |
Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
|
CN102549159B
(zh)
|
2009-03-17 |
2016-08-10 |
库尔纳公司 |
通过抑制针对δ样1同源物(DLK1)的天然反义转录物来治疗DLK1相关的疾病
|
WO2010111231A1
(en)
|
2009-03-23 |
2010-09-30 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
KR20110140128A
(ko)
|
2009-03-27 |
2011-12-30 |
고조 인더스트리즈, 인크 |
포자-표면 상호작용을 길항하는 화합물을 스크리닝 및 사용하기 위한 조성물 및 방법
|
US8343976B2
(en)
|
2009-04-20 |
2013-01-01 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising pyrazole derivatives
|
US9155754B2
(en)
|
2009-05-06 |
2015-10-13 |
Curna, Inc. |
Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
|
KR101722541B1
(ko)
|
2009-05-06 |
2017-04-04 |
큐알엔에이, 인크. |
Ttp에 대한 천연 안티센스 전사체의 억제에 의한 트리스테트라프롤린 관련된 질환의 치료
|
EP2427554B1
(en)
|
2009-05-08 |
2016-11-16 |
CuRNA, Inc. |
Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
|
DK2432881T3
(en)
|
2009-05-18 |
2018-02-26 |
Curna Inc |
TREATMENT OF REPROGRAMMING FACTOR-RELATED DISEASES BY INHIBITING NATURAL ANTISENSE TRANSCRIPTS TO A REPROGRAMMING FACTOR
|
US8895527B2
(en)
|
2009-05-22 |
2014-11-25 |
Curna, Inc. |
Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3
|
CN103221541B
(zh)
|
2009-05-28 |
2017-03-01 |
库尔纳公司 |
通过抑制抗病毒基因的天然反义转录物来治疗抗病毒基因相关疾病
|
CA2765509C
(en)
|
2009-06-16 |
2021-08-17 |
Joseph Collard |
Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
|
JP5944311B2
(ja)
|
2009-06-16 |
2016-07-05 |
クルナ・インコーポレーテッド |
コラーゲン遺伝子に対する天然アンチセンス転写物の抑制によるコラーゲン遺伝子関連疾患の治療
|
US8859515B2
(en)
|
2009-06-24 |
2014-10-14 |
Curna, Inc. |
Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
|
EP2446037B1
(en)
|
2009-06-26 |
2016-04-20 |
CuRNA, Inc. |
Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
|
US20120122711A1
(en)
*
|
2009-07-15 |
2012-05-17 |
Heath James R |
Screening of biopolymers
|
CN102498123A
(zh)
*
|
2009-07-15 |
2012-06-13 |
新加坡科技研究局 |
改进的生物聚合物筛选
|
US9863956B2
(en)
|
2009-07-22 |
2018-01-09 |
Agency For Science, Technology And Research |
Differentiation of isobaric amino acids and other species
|
CN102712925B
(zh)
|
2009-07-24 |
2017-10-27 |
库尔纳公司 |
通过抑制sirtuin(sirt)的天然反义转录物来治疗sirtuin(sirt)相关性疾病
|
IN2012DN00303A
(es)
|
2009-07-24 |
2015-05-08 |
Univ California |
|
KR101802536B1
(ko)
|
2009-08-05 |
2017-11-28 |
큐알엔에이, 인크. |
인슐린 유전자 (ins)에 대한 자연 안티센스 전사체의 저해에 의한 인슐린 유전자 (ins) 관련된 질환의 치료
|
US9044493B2
(en)
|
2009-08-11 |
2015-06-02 |
Curna, Inc. |
Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin
|
US8383360B2
(en)
|
2009-08-14 |
2013-02-26 |
The Regents Of The University Of California |
Methods of diagnosing and treating autism
|
EP2467398B1
(en)
|
2009-08-20 |
2019-10-09 |
Poseida Therapeutics, Inc. |
Trpc4 inhibitors and uses thereof
|
JP5943836B2
(ja)
|
2009-08-21 |
2016-07-05 |
カッパーアールエヌエー,インコーポレイテッド |
‘hsp70相互作用タンパク質c末端’(chip)に対する天然アンチセンス転写産物の阻害によるchip関連疾患の治療
|
WO2011028390A1
(en)
|
2009-08-24 |
2011-03-10 |
St. Jude Children's Research Hospital |
Compositions and methods for potentiating interleukin-35
|
WO2011031482A2
(en)
|
2009-08-25 |
2011-03-17 |
Curna, Inc. |
Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
|
ES2664591T3
(es)
|
2009-09-25 |
2018-04-20 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la filagrina (flg) mediante la modulación de la expresión y actividad del gen FLG
|
US10520500B2
(en)
|
2009-10-09 |
2019-12-31 |
Abdeslam El Harrak |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
ES2365343B1
(es)
|
2009-11-19 |
2012-07-10 |
Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii |
Uso de cd98 como marcador de receptividad endometrial.
|
AU2010321885B2
(en)
|
2009-11-20 |
2015-12-24 |
The Regents Of The University Of California |
Epithelial membrane protein-2 (EMP2) and proliferative vitreoretinopathy (PVR)
|
EA201200617A1
(ru)
*
|
2009-11-23 |
2012-11-30 |
Серулин Фарма Инк. |
Полимеры на основе циклодекстрина для доставки лекарственных средств
|
NO2513310T3
(es)
|
2009-12-16 |
2018-03-31 |
|
|
RU2609631C2
(ru)
|
2009-12-23 |
2017-02-02 |
Курна, Инк. |
Лечение заболеваний, связанных с фактором роста гепатоцитов (фрг), посредством ингибирования природного антисмыслового транскрипта к фрг
|
EP2517025B1
(en)
|
2009-12-23 |
2019-11-27 |
Bio-Rad Laboratories, Inc. |
Methods for reducing the exchange of molecules between droplets
|
EP2515947B1
(en)
|
2009-12-23 |
2021-10-06 |
CuRNA, Inc. |
Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
|
CA2785173A1
(en)
|
2009-12-29 |
2011-07-28 |
Curna, Inc. |
Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
|
ES2585829T3
(es)
|
2009-12-29 |
2016-10-10 |
Curna, Inc. |
Tratamiento de las enfermedades relacionadas con la proteína tumoral 63 (p63) por inhibición de transcripción antisentido natural a p63
|
RU2616283C2
(ru)
|
2009-12-31 |
2017-04-13 |
Курна, Инк. |
Лечение заболеваний, связанных с субстратом рецептора инсулина 2 (irs2), путем ингибирования природного антисмыслового транскрипта к irs2
|
US8946181B2
(en)
|
2010-01-04 |
2015-02-03 |
Curna, Inc. |
Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
|
KR101853509B1
(ko)
|
2010-01-06 |
2018-04-30 |
큐알엔에이, 인크. |
췌장 발달 유전자에 대한 천연 안티센스 전사체의 억제에 의한 췌장 발달 유전자와 관련된 질환의 치료
|
DK2524039T3
(en)
|
2010-01-11 |
2018-03-12 |
Curna Inc |
TREATMENT OF GENDER HORMON-BINDING GLOBULIN (SHBG) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTS TO SHBG
|
US9073033B2
(en)
|
2010-01-19 |
2015-07-07 |
Illumina, Inc. |
Methods and compositions for processing chemical reactions
|
WO2011091435A2
(en)
|
2010-01-25 |
2011-07-28 |
Mount Sinai School Of Medicine |
Methods of treating liver disease
|
CA2786568A1
(en)
|
2010-01-25 |
2011-07-28 |
Curna, Inc. |
Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
|
WO2011094759A2
(en)
|
2010-02-01 |
2011-08-04 |
The Regents Of The University Of California |
Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
EP2534267B1
(en)
|
2010-02-12 |
2018-04-11 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
CN102844435B
(zh)
|
2010-02-22 |
2017-05-10 |
库尔纳公司 |
通过抑制吡咯啉‑5‑羧酸还原酶1(pycr1)的天然反义转录物而治疗pycr1相关疾病
|
ES2657969T3
(es)
|
2010-04-02 |
2018-03-07 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con el Factor 3 estimulante de colonias (CSF3) por inhibición del transcrito antisentido natural a CSF3
|
JP5978203B2
(ja)
|
2010-04-09 |
2016-08-24 |
カッパーアールエヌエー,インコーポレイテッド |
Fgf21に対する天然アンチセンス転写物の阻害による線維芽細胞増殖因子(fgf21)線維芽細胞増殖因子fgf21)関連疾患の治療
|
EP3540059A1
(en)
|
2010-04-16 |
2019-09-18 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
EP2957636B1
(en)
|
2010-05-03 |
2020-04-01 |
CuRNA, Inc. |
Treatment of sirtuin 3 (sirt3) related diseases by inhibition of natural antisense transcript to sirt3
|
TWI586356B
(zh)
|
2010-05-14 |
2017-06-11 |
可娜公司 |
藉由抑制par4天然反股轉錄本治療par4相關疾病
|
EP2576784B1
(en)
|
2010-05-26 |
2017-11-15 |
CuRNA, Inc. |
Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra
|
WO2011150005A2
(en)
|
2010-05-26 |
2011-12-01 |
Opko Curna Llc |
Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
|
EP2400304A1
(en)
|
2010-06-22 |
2011-12-28 |
Centro de Investigación Cooperativa En Biomateriales ( CIC biomaGUNE) |
Method for the characterization of intermolecular interactions
|
PT2585596T
(pt)
|
2010-06-23 |
2021-03-23 |
Curna Inc |
Tratamento de doenças relacionadas com a subunidade alfa de canais de sódio dependentes de voltagem (scna) por inibição da transcrição antissentido natural para scna
|
NO2593547T3
(es)
|
2010-07-14 |
2018-04-14 |
|
|
WO2012018638A2
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
|
WO2012018639A2
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
|
SG10201506785SA
(en)
*
|
2010-08-27 |
2015-10-29 |
Agency Science Tech & Res |
Peptide libraries for screening and other applications
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
WO2012047956A2
(en)
|
2010-10-06 |
2012-04-12 |
Opko Curna Llc |
Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
|
WO2012052391A1
(en)
|
2010-10-19 |
2012-04-26 |
Glaxo Group Limited |
Polypeptide with jmjd3 catalytic activity
|
JP6049623B2
(ja)
|
2010-10-22 |
2016-12-21 |
カッパーアールエヌエー,インコーポレイテッド |
α‐L‐イズロニダーゼ(IDUA)への天然アンチセンス転写物の阻害によるIDUA関連疾患の治療
|
WO2012068340A2
(en)
|
2010-11-18 |
2012-05-24 |
Opko Curna Llc |
Antagonat compositions and methods of use
|
WO2012074855A2
(en)
|
2010-11-22 |
2012-06-07 |
The Regents Of The University Of California |
Methods of identifying a cellular nascent rna transcript
|
CN103459599B
(zh)
|
2010-11-23 |
2017-06-16 |
库尔纳公司 |
通过抑制nanog的天然反义转录物而治疗nanog相关疾病
|
KR20200113286A
(ko)
|
2010-12-22 |
2020-10-06 |
페이트 세러퓨틱스, 인코포레이티드 |
단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
|
WO2012109495A1
(en)
|
2011-02-09 |
2012-08-16 |
Metabolic Solutions Development Company, Llc |
Cellular targets of thiazolidinediones
|
EP3859011A1
(en)
|
2011-02-11 |
2021-08-04 |
Bio-Rad Laboratories, Inc. |
Methods for forming mixed droplets
|
EP3736281A1
(en)
|
2011-02-18 |
2020-11-11 |
Bio-Rad Laboratories, Inc. |
Compositions and methods for molecular labeling
|
EP3502236B1
(en)
|
2011-02-18 |
2023-08-23 |
The Scripps Research Institute |
Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
|
CN103534355A
(zh)
|
2011-03-04 |
2014-01-22 |
英特瑞克斯顿股份有限公司 |
条件性表达蛋白质的载体
|
WO2012119989A2
(en)
|
2011-03-04 |
2012-09-13 |
Oryzon Genomics, S.A. |
Methods and antibodies for the diagnosis and treatment of cancer
|
CN103517726B
(zh)
|
2011-04-05 |
2016-08-17 |
优势医疗 |
用于改善脑损伤后影响脑血流的结果的脑室内药物递送系统
|
US20120301904A1
(en)
|
2011-04-26 |
2012-11-29 |
Prosetta Antiviral, Inc |
Multiprotein assemblies
|
EA027558B1
(ru)
|
2011-05-19 |
2017-08-31 |
Эйджена Байосайенс, Инк. |
Способ обнаружения мультиплексных нуклеиновых кислот
|
EP3709018A1
(en)
|
2011-06-02 |
2020-09-16 |
Bio-Rad Laboratories, Inc. |
Microfluidic apparatus for identifying components of a chemical reaction
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
US9244074B2
(en)
|
2011-06-07 |
2016-01-26 |
University Of Hawaii |
Biomarker of asbestos exposure and mesothelioma
|
WO2012170742A2
(en)
|
2011-06-07 |
2012-12-13 |
University Of Hawaii |
Treatment and prevention of cancer with hmgb1 antagonists
|
JP6188686B2
(ja)
|
2011-06-09 |
2017-08-30 |
カッパーアールエヌエー,インコーポレイテッド |
フラタキシン(fxn)への天然アンチセンス転写物の阻害によるfxn関連疾患の治療
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
WO2013018690A1
(ja)
|
2011-07-29 |
2013-02-07 |
国立大学法人徳島大学 |
Erap1由来ペプチド及びその使用
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
WO2013036403A1
(en)
|
2011-09-06 |
2013-03-14 |
Curna, Inc. |
TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES
|
CA2851828A1
(en)
|
2011-10-28 |
2013-05-02 |
Presage Biosciences, Inc. |
Methods for drug delivery
|
LT2790687T
(lt)
|
2011-12-16 |
2018-12-10 |
Poseida Therapeutics, Inc. |
Trpc4 moduliatoriai, skirti panaudoti skausmo gydymui arba prevencijai
|
CA3191015A1
(en)
*
|
2012-02-07 |
2013-08-15 |
Vibrant Holdings, Llc |
Substrates, peptide arrays, and methods
|
WO2013123305A1
(en)
|
2012-02-16 |
2013-08-22 |
The Penn State Research Foundation |
Modulators of acyl-coa lysocardiolipin acyltransferase 1 ( alcat1) and uses thereof
|
US9408832B2
(en)
|
2012-03-14 |
2016-08-09 |
University Of Central Florida Research Foundation, Inc. |
LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
|
TR201815503T4
(tr)
|
2012-03-15 |
2018-11-21 |
Curna Inc |
Beyin kaynaklı nörotrofik faktör (bknf) ile ilişkili hastalıkların doğal antisens transkriptinin bknf'ye inhibisyonu ile muamelesi.
|
JP6399660B2
(ja)
|
2012-04-10 |
2018-10-03 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
癌治療用組成物および方法
|
CA2871462A1
(en)
|
2012-04-24 |
2013-10-31 |
University Of Miami |
Perforin 2 defense against invasive and multidrug resistant pathogens
|
US9399019B2
(en)
|
2012-05-09 |
2016-07-26 |
Evonik Corporation |
Polymorph compositions, methods of making, and uses thereof
|
US9347948B2
(en)
|
2012-06-04 |
2016-05-24 |
The Scripps Research Institute |
Phenyl glyoxal probes
|
CA2879542A1
(en)
|
2012-07-25 |
2014-01-30 |
Salk Institute For Biological Studies |
Regulating the interaction between tam ligands and lipid membranes with exposed phosphatidylserine
|
WO2014036528A2
(en)
|
2012-08-31 |
2014-03-06 |
Ixchel Pharma, Llc |
Agents useful for treating obesity, diabetes and related disorders
|
BR112015006828A8
(pt)
|
2012-09-26 |
2019-09-17 |
Univ California |
composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
|
US10006909B2
(en)
|
2012-09-28 |
2018-06-26 |
Vibrant Holdings, Llc |
Methods, systems, and arrays for biomolecular analysis
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
EP2912194B1
(en)
|
2012-10-26 |
2019-05-08 |
Memorial Sloan-Kettering Cancer Center |
Androgen receptor variants and methods for making and using
|
US20140120116A1
(en)
|
2012-10-26 |
2014-05-01 |
The Chinese University Of Hong Kong |
Treatment of cancer using smad3 inhibitor
|
US10286376B2
(en)
|
2012-11-14 |
2019-05-14 |
Vibrant Holdings, Llc |
Substrates, systems, and methods for array synthesis and biomolecular analysis
|
WO2014093406A1
(en)
|
2012-12-10 |
2014-06-19 |
Fred Hutchinson Cancer Research Center |
Methods for screening
|
EP2934572A4
(en)
|
2012-12-20 |
2016-11-23 |
Biomatrica Inc |
FORMULATIONS AND METHODS FOR STABILIZING PCR REAGENTS
|
EP2954323B1
(en)
|
2013-02-07 |
2020-04-15 |
The Regents of The University of California |
Use of translational profiling to identify target molecules for therapeutic treatment
|
CA2923379C
(en)
|
2013-02-15 |
2023-01-03 |
Vibrant Holdings, Llc |
Methods and compositions for amplified electrochemiluminescence detection
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
US9428537B2
(en)
|
2013-03-15 |
2016-08-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA derived small RNAs (tsRNAs) involved in cell viability
|
EP2986717A1
(en)
|
2013-04-19 |
2016-02-24 |
The Regents of The University of California |
Lone star virus
|
US9950036B2
(en)
|
2013-08-21 |
2018-04-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mood and stress related disorders
|
US10626178B2
(en)
|
2013-08-21 |
2020-04-21 |
Raz Yirmiya |
Treatment of mood and stress related disorders
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
TWI659021B
(zh)
|
2013-10-10 |
2019-05-11 |
亞瑞克西斯製藥公司 |
Kras g12c之抑制劑
|
US9644037B2
(en)
|
2013-10-18 |
2017-05-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 and their use
|
WO2015089338A2
(en)
|
2013-12-11 |
2015-06-18 |
Sloan-Kettering Institute For Cancer Research |
Glucocorticoid inhibitors for treatment of prostate cancer
|
US10280169B2
(en)
|
2013-12-11 |
2019-05-07 |
Biogen Ma Inc. |
Biaryl bruton's tyrosine kinase inhibitors
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
EP3805369A1
(en)
|
2014-03-04 |
2021-04-14 |
Fate Therapeutics, Inc. |
Improved reprogramming methods and cell culture platforms
|
WO2015136509A2
(en)
|
2014-03-14 |
2015-09-17 |
Genesis Theranostix Korlatolt Felelossegu Tarsasag |
Diagnostic and therapeutic targets for preeclampsia and closely related complications of pregnancy
|
CN113826612B
(zh)
|
2014-06-10 |
2022-11-22 |
生物马特里卡公司 |
在环境温度下稳定凝血细胞
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
WO2016049524A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2016049568A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Methods and compositions for inhibition of ras
|
KR20180005178A
(ko)
|
2015-04-10 |
2018-01-15 |
아락세스 파마 엘엘씨 |
치환된 퀴나졸린 화합물 및 이의 사용방법
|
WO2016168540A1
(en)
|
2015-04-15 |
2016-10-20 |
Araxes Pharma Llc |
Fused-tricyclic inhibitors of kras and methods of use thereof
|
JP2018512880A
(ja)
|
2015-04-24 |
2018-05-24 |
アジーナ バイオサイエンス, インコーポレイテッド |
少量の対立遺伝子および多型の同定ならびに定量のためのマルチプレックス法
|
JP2018512881A
(ja)
|
2015-04-24 |
2018-05-24 |
アジーナ バイオサイエンス, インコーポレイテッド |
少数バリアントの検出および定量のための方法マルチプレックス法
|
US10196701B2
(en)
|
2015-06-01 |
2019-02-05 |
The Penn State Research Foundation |
Hepatitis B virus capsid assembly
|
US20160370380A1
(en)
*
|
2015-06-16 |
2016-12-22 |
Pharmaseq, Inc. |
Combinatorial antibody diagnostic
|
WO2016209772A2
(en)
|
2015-06-22 |
2016-12-29 |
Proteovista Llc |
Snp arrays
|
WO2016207313A1
(en)
|
2015-06-24 |
2016-12-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for detecting protein-protein interactions
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
US10858343B2
(en)
|
2015-09-28 |
2020-12-08 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10875842B2
(en)
|
2015-09-28 |
2020-12-29 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
WO2017058915A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10730867B2
(en)
|
2015-09-28 |
2020-08-04 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
EP3356359B1
(en)
|
2015-09-28 |
2021-10-20 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
US10689356B2
(en)
|
2015-09-28 |
2020-06-23 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10647703B2
(en)
|
2015-09-28 |
2020-05-12 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
CN117737124A
(zh)
|
2015-10-16 |
2024-03-22 |
菲特治疗公司 |
用于诱导和维护基态多能性的平台
|
JP2018533939A
(ja)
|
2015-10-19 |
2018-11-22 |
アラクセス ファーマ エルエルシー |
Rasの阻害剤をスクリーニングするための方法
|
KR20180081596A
(ko)
|
2015-11-16 |
2018-07-16 |
아락세스 파마 엘엘씨 |
치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법
|
AU2016368265B2
(en)
|
2015-12-08 |
2021-10-28 |
Biomatrica, Inc. |
Reduction of erythrocyte sedimentation rate
|
WO2017100546A1
(en)
|
2015-12-09 |
2017-06-15 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
WO2017139329A1
(en)
|
2016-02-09 |
2017-08-17 |
Alexander Krantz |
Site-selective functionalization of proteins using traceless affinity lables
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
WO2018036503A1
(en)
|
2016-08-25 |
2018-03-01 |
The Chinese University Of Hong Kong |
Fecal bacterial markers for colorectal cancer
|
US10280172B2
(en)
|
2016-09-29 |
2019-05-07 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10726944B2
(en)
|
2016-10-04 |
2020-07-28 |
International Business Machines Corporation |
Recommending novel reactants to synthesize chemical products
|
EP3523289A1
(en)
|
2016-10-07 |
2019-08-14 |
Araxes Pharma LLC |
Heterocyclic compounds as inhibitors of ras and methods of use thereof
|
CA3047125A1
(en)
|
2016-12-15 |
2018-06-21 |
The Regents Of The University Of California |
Compositions and methods for treating cancer
|
US11274093B2
(en)
|
2017-01-26 |
2022-03-15 |
Araxes Pharma Llc |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
EP3573970A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer
|
EP3573967A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused hetero-hetero bicyclic compounds and methods of use thereof
|
WO2018140599A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
WO2018140513A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
US11771703B2
(en)
|
2017-03-17 |
2023-10-03 |
The Johns Hopkins University |
Targeted epigenetic therapy against distal regulatory element of TGFβ2 expression
|
BR112019019407A2
(pt)
|
2017-03-20 |
2020-05-26 |
Genocea Biosciences Inc. |
Métodos de tratamento
|
WO2018175324A1
(en)
|
2017-03-20 |
2018-09-27 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
SG10202113146UA
(en)
|
2017-05-25 |
2021-12-30 |
Araxes Pharma Llc |
Covalent inhibitors of kras
|
US11639346B2
(en)
|
2017-05-25 |
2023-05-02 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
|
TW201906832A
(zh)
|
2017-05-25 |
2019-02-16 |
美商亞瑞克西斯製藥公司 |
用於癌症治療之化合物及其使用方法
|
US10538808B2
(en)
|
2017-05-26 |
2020-01-21 |
Vibrant Holdings, Llc |
Photoactive compounds and methods for biomolecule detection and sequencing
|
ES2947336T3
(es)
|
2017-09-01 |
2023-08-07 |
Univ Johns Hopkins |
Terapia epigenética dirigida para el aneurisma aórtico hereditario
|
WO2019070908A1
(en)
|
2017-10-03 |
2019-04-11 |
Cedars-Sinai Medical Center |
METHODS OF TARGETING THE PD1 PATHWAY OF THE IMMUNE CONTROL POINT FOR THE TREATMENT OF PULMONARY FIBROSIS
|
EP3703676A4
(en)
|
2017-11-04 |
2021-12-15 |
Advanced Proteome Therapeutics, Inc. |
COMPOSITION AND PROCESS FOR MODIFYING POLYPEPTIDES
|
WO2020092379A1
(en)
|
2018-10-29 |
2020-05-07 |
Genocea Biosciences, Inc. |
Treatment methods
|
WO2020087107A1
(en)
|
2018-10-31 |
2020-05-07 |
The University Of Sydney |
Compositions and methods for treating viral infections
|
WO2020097261A1
(en)
|
2018-11-06 |
2020-05-14 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and methods for treating beta-globinopathies
|
SG11202107720UA
(en)
|
2019-01-31 |
2021-08-30 |
Agency Science Tech & Res |
Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
|
US20220249559A1
(en)
|
2019-05-13 |
2022-08-11 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
RU2699563C1
(ru)
*
|
2019-05-29 |
2019-09-06 |
Федеральное государственное бюджетное учреждение "Петербургский институт ядерной физики им. Б.П. Константинова Национального исследовательского центра "Курчатовский институт" (НИЦ "Курчатовский институт-ПИЯФ) |
Модифицированный синтетический аналог природного опиоидного пептида энкефалина
|
DE102020202529A1
(de)
*
|
2020-02-27 |
2021-09-02 |
Robert Bosch Gesellschaft mit beschränkter Haftung |
Verfahren zur Identifikation einer Wirkstoffkombination
|
US11965162B2
(en)
|
2020-04-16 |
2024-04-23 |
The Johns Hopkins University |
MicroRNA and inhibitors thereof and methods of treatment
|
WO2023081167A2
(en)
|
2021-11-02 |
2023-05-11 |
The Regents Of The University Of California |
P-selectin mutants and modulation of integrin-mediated signaling
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
WO2023146807A1
(en)
|
2022-01-25 |
2023-08-03 |
The Regents Of The University Of California |
Vegf mutants and modulation of integrin-mediated signaling
|